Richard Marshak - 30 Jun 2026 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Reporting relationship
Chief Commercial Officer
Issuer ticker
TLSI
Reported as of
30 Jun 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
01 Jul 2026, 16:02:47 UTC
Prior SEC filing
19 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mary Szela, Attorney-in-Fact

Key filing fact

Richard Marshak filed Form 4 for TriSalus Life Sciences, Inc. (TLSI) on 01 Jul 2026.

Key facts

  • This page summarizes Richard Marshak's Form 4 filing for TriSalus Life Sciences, Inc. (TLSI).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 01 Jul 2026, 16:02.

Change

  • Previous filing in this sequence was filed on 19 May 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001982638 Primary reporting owner

Marshak Richard

Relationship
Chief Commercial Officer
Address
6272 W. 91ST AVENUE, WESTMINSTER
Signature
/s/ Mary Szela, Attorney-in-Fact
Signature date
01 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TLSI transaction

Common Stock

Award

Transaction value
Shares
+561
Change %
+0.44%
Price
$3.87*
Shares after
128,319
Date
30 Jun 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .